United States · FDA National Drug Code directory

QUDEXY XR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0245-1072_5cfd7234-5efc-4cb8-b69c-7e68b9f1a94f
Product NDC: 0245-1072
Form: CAPSULE, EXTENDED RELEASE
Composition / generic term: Topiramate
Labeler: Upsher-Smith Laboratories, LLC
Marketing category: NDA
Marketing start / end (source format): 20140411
Source listing expiry: 20271231

Source-listed ingredients

TOPIRAMATE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 CARTON (0245-1072-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 0245-1072-30
1 BOTTLE in 1 CARTON (0245-1072-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 0245-1072-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →